J. David Boyle II
2008
In 2008, J. David Boyle II earned a total compensation of $839.3K as Chief Financial Officer and Secretary at Sarepta Therapeutics.
Compensation breakdown
| Bonus | $72,973 |
|---|---|
| Option Awards | $512,300 |
| Salary | $93,462 |
| Other | $160,550 |
| Total | $839,285 |
Boyle received $512.3K in option awards, accounting for 61% of the total pay in 2008.
Boyle also received $73K in bonus, $93.5K in salary and $160.6K in other compensation.
Rankings
In 2008, J. David Boyle II's compensation ranked 4,935th out of 9,135 executives tracked by ExecPay. In other words, Boyle earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,935 out of 9,135 | 46th |
Division Manufacturing | 1,779 out of 3,436 | 48th |
Major group Chemicals And Allied Products | 353 out of 815 | 57th |
Industry group Drugs | 213 out of 597 | 64th |
Industry Pharmaceutical Preparations | 156 out of 408 | 62nd |
Source: SEC filing on May 4, 2010.
Boyle's colleagues
We found seven more compensation records of executives who worked with J. David Boyle II at Sarepta Therapeutics in 2008.
2008
Leslie Hudson
Sarepta Therapeutics
Chief Executive Officer
2008
Alan Timmins
Sarepta Therapeutics
Chief Operating Officer
2008
Dwight Weller
Sarepta Therapeutics
Senior Vice President of Chemistry and Manufacturing
2008
Peter O'Hanley
Sarepta Therapeutics
SVP of Clinical Development and Regulatory Affairs
2008
Mark Webber
Sarepta Therapeutics
Chief Financial Officer
2008
Patrick Iversen
Sarepta Therapeutics
Senior Vice President of Strategic Alliances
2008
K Forrest
Sarepta Therapeutics